Scarica l'app Stockscreener
21.06
0.86%
0.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$20.88
Aprire:
$21.07
Volume 24 ore:
1.01M
Relative Volume:
0.93
Capitalizzazione di mercato:
$11.21B
Reddito:
$22.44B
Utile/perdita netta:
$1.35B
Rapporto P/E:
11.08
EPS:
1.9002
Flusso di cassa netto:
$2.03B
1 W Prestazione:
-5.35%
1M Prestazione:
-5.69%
6M Prestazione:
-10.80%
1 anno Prestazione:
-22.46%
Intervallo 1D:
$20.91
$21.24
Intervallo di 1 settimana:
$20.23
$22.68
Portata 52W:
$20.02
$27.64
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Nome
Fresenius Medical Care Ag Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare FMS vs HCA, THC, EHC, DVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
21.06 | 11.21B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
451.09 | 97.66B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
263.78 | 21.24B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
123.33 | 12.17B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
179.25 | 11.44B | 13.84B | 1.10B | 1.49B | 10.42 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-29 | Downgrade | Berenberg | Buy → Hold |
| 2026-07-28 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| 2026-07-16 | Iniziato | Bernstein | Mkt Perform |
| 2026-01-20 | Downgrade | Goldman | Buy → Neutral |
| 2025-10-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-09-02 | Downgrade | UBS | Neutral → Sell |
| 2024-12-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Iniziato | Berenberg | Buy |
| 2024-01-08 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Aggiornamento | Societe Generale | Hold → Buy |
| 2023-08-14 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Ripresa | Citigroup | Neutral |
| 2023-07-12 | Iniziato | Goldman | Buy |
| 2023-03-07 | Iniziato | Bernstein | Mkt Perform |
| 2023-01-03 | Downgrade | Jefferies | Buy → Underperform |
| 2022-10-26 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-06-27 | Aggiornamento | Jefferies | Underperform → Buy |
| 2022-02-11 | Downgrade | Jefferies | Hold → Underperform |
| 2021-11-23 | Iniziato | HSBC Securities | Hold |
| 2021-11-11 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-02-04 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2020-05-20 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-06-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Aggiornamento | UBS | Neutral → Buy |
| 2018-08-28 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2018-07-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Aggiornamento | UBS | Sell → Neutral |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2016-07-08 | Aggiornamento | Jefferies | Underperform → Hold |
| 2016-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2015-08-13 | Downgrade | Societe Generale | Buy → Hold |
| 2015-07-31 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Reiterato | Feltl & Co. | Hold |
| 2013-01-14 | Aggiornamento | HSBC Securities | Neutral → Overweight |
Mostra tutto
Fresenius Medical Care Ag Adr Borsa (FMS) Ultime notizie
Fresenius Medical Care AG : Bernstein reiterates its Neutral rating - www.marketscreener.com
Fresenius Medical Care replaces CEO, stock under pressure - marketscreener.com
Fresenius Medical Care AG (FMS) Shares Fall 7.7% -- What GF Scor - GuruFocus
Fresenius Medical Care AG Stock (FMS) Moved Down by 7.45% on Oct 7: What Investors Need To Know - TradingKey
Fresenius Medical Care AG : JP Morgan remains a Sell rating - www.marketscreener.com
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - TradingView
Fresenius Medical Care tumbles on CEO transition announcement - Investing.com
Fresenius Medical Care (FMS) Names Shervin Korangy as New CEO an - GuruFocus
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth - Fresenius Medical Care
Fresenius Medical Care AG : Change in CEO – Shervin J. Korangy Succeeds Helen Giza - www.marketscreener.com
Fresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains Limited - Seeking Alpha
XS2084488209 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care AG (FME.DE) Stock Price, News, Quote & History - ca.finance.yahoo.com
Turning experience into impact: Vanessa Evans’ journey through kidney disease - Fresenius Medical Care
XS323349908 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care AG : Goldman Sachs remains Neutral - marketscreener.com
Fresenius Medical Care AG (FMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Rating Lowered by Berenberg Bank - MarketBeat
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth - TradingView
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth - Yahoo Finance
Fresenius Medical Care AG & Co KGaA Accelerating Growth in Home Dialysis Call Transcript - GuruFocus
Fresenius Medical Care AG : Berenberg is Neutral - marketscreener.com
Fresenius Medical Care stock at EUR 40.44 on September 28, 2026 - ad-hoc-news.de
Fresenius Medical Care AG (FME) Reports Goldman Sachs Voting Rights Notification - TradingView
Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - TradingView
Fresenius Medical Care AG : Release of a capital market information - marketscreener.com
Fresenius Medical Care AG (FME) Updates Share Buyback - TradingView
Fresenius Medical Care AG (FME) Updates Share Buyback Totals - TradingView
Weekly Recap: China strategy shift and €110M one-time Q3 2026 charges - TradingView
XS3036647777 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Benzinga
Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business - finance.yahoo.com
A planned dialysis business exit in China carries expected one-time costs for Fresenius Medical Care (FMS). - Stock Titan
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages - MarketBeat
Strategic shift in China costs Fresenius Medical Care €110m - marketscreener.com
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership - Fresenius Medical Care
Hackers attack dialysis group Fresenius Medical Care - marketscreener.com
Fresenius Medical Care stock falls 0.8 percent ahead of the open - AD HOC NEWS
Statement Regarding Cybersecurity Incident - Fresenius Medical Care
Fresenius Medical Care : Statement Regarding Cybersecurity Incident - marketscreener.com
Fresenius Medical Care stock trails the DAX after a 0.8 percent fall - AD HOC NEWS
Fresenius Medical Care AG (FME) Updates Share Buyback Totals - tradingview.com
Fresenius Medical Care AG : Release of a capital market information - tradingview.com
Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 15% Potential Upside Amidst Diverse Analyst Opinions - DirectorsTalk Interviews
Fresenius Medical Care AG (FMS) Stock Down 3.9% -- Now Undervalued? GF Score: 74/100 - GuruFocus
Fresenius Medical Care AG : Release of a capital market information - marketscreener.com
Fresenius Medical Care stock gains as J.P. Morgan sticks to Sell rating and consensus targets diverg - ad-hoc-news.de
Fresenius Medical Care stock stabilizes as JPMorgan stays cautious on medtech outlook - ad-hoc-news.de
Fresenius Medical Care Ag Adr Azioni (FMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.26%
0.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):